Compass Labs

It is reported that AminoChain is building an L2 blockchain protocol that connects corporate medical institutions, and on top of this protocol, it is developing decentralized healthcare applications owned by users. The first application built on AminoChain is a biomaterials marketplace that allows researchers to search for and obtain permission to use biological samples through a network of biomaterial repositories. Patients can track the use of their samples, learn from the new insights generated from these samples, and earn money by selling them.